MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q2
hinzugefügt 23.05.2026
Agile Therapeutics Langfristiger Schuldenstrom 2011-2026 | AGRX
Langfristiger Schuldenstrom Jährlich Agile Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 366 K | 319 K | 175 K | 138 K | 172 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 366 K | 138 K | 234 K |
Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
956 K | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
59.5 K | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
468 K | $ 5.47 | -2.41 % | $ 81.3 M | USA |
 |
HEXO Corp.
HEXO
|
914 K | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
12.5 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
100 K | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
1.08 M | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
343 K | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
4.36 M | - | - | $ 754 M | USA |
 |
Alimera Sciences
ALIM
|
634 K | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
337 K | $ 2.63 | -0.19 % | $ 1.01 B | Canada |
 |
Athenex
ATNX
|
2.09 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
887 K | $ 38.59 | -0.87 % | $ 1.42 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
582 K | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
13 M | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
4.95 M | $ 2.33 | -3.53 % | $ 295 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.53 M | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
8.89 M | $ 22.8 | 0.26 % | $ 1.05 B | USA |
 |
Canopy Growth Corporation
CGC
|
8.37 M | $ 0.94 | -3.9 % | $ 280 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
58 K | $ 1.11 | -0.89 % | $ 1.38 M | USA |
 |
Aurora Cannabis
ACB
|
5.38 M | $ 3.0 | 1.53 % | $ 164 M | Canada |
 |
Solid Biosciences
SLDB
|
2.1 M | $ 7.17 | -2.58 % | $ 627 M | USA |
 |
Jupiter Wellness
JUPW
|
23.5 K | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
2.06 M | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
1.03 M | $ 1.0 | -2.43 % | $ 95.3 M | Canada |
 |
Tilray
TLRY
|
2.47 M | $ 4.95 | -1.2 % | $ 3.06 B | Canada |
 |
Evolus
EOLS
|
2.53 M | $ 6.76 | 0.07 % | $ 436 M | USA |
 |
Sundial Growers
SNDL
|
35.5 M | $ 1.42 | -1.05 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
2.4 M | $ 8.12 | -2.17 % | $ 434 M | USA |
 |
cbdMD
YCBD
|
778 K | $ 0.67 | -1.62 % | $ 2.7 M | USA |
 |
Veru
VERU
|
759 K | $ 3.0 | -4.15 % | $ 43.9 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.05 M | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
240 K | $ 23.5 | - | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
1.21 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
613 K | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
61 M | $ 4.97 | -0.4 % | $ 1.84 B | Canada |
 |
PetIQ
PETQ
|
7.61 M | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
1.1 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
1.25 M | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
483 K | $ 4.04 | -1.22 % | $ 202 M | USA |
 |
PLx Pharma
PLXP
|
622 K | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
109 M | $ 16.17 | -0.95 % | $ 18.8 B | USA |
 |
Zomedica Corp.
ZOM
|
717 K | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
215 K | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
1.16 M | $ 0.67 | 5.0 % | $ 24.1 M | USA |
 |
Tricida
TCDA
|
2.74 M | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
71.6 K | $ 0.75 | -0.84 % | $ 3.22 M |  China |
 |
TherapeuticsMD
TXMD
|
975 K | $ 2.23 | -2.15 % | $ 25.8 M | USA |